Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Outcomes of Hypothermia in Addition to Decompressive Hemicraniectomy in Treatment of Malignant Middle Cerebral Artery Stroke

Outcomes of Hypothermia in Addition to Decompressive Hemicraniectomy in Treatment of Malignant... Key PointsQuestionDoes moderate hypothermia after decompressive hemicraniectomy reduce early mortality in patients with malignant stroke? FindingsThis randomized clinical trial investigated the effects and safety of moderate hypothermia (temperature, 33°C ± 1°C) after hemicraniectomy in 50 patients 60 years and younger who had malignant stroke. Mortality at day 14 was not significantly different between the hypothermia group and the control group; the trial was terminated early for safety reasons because of a higher rate of serious adverse events in the hypothermia group. MeaningModerate hypothermia after hemicraniectomy did not improve early mortality but may be harmful to patients with malignant stroke. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Neurology American Medical Association

Outcomes of Hypothermia in Addition to Decompressive Hemicraniectomy in Treatment of Malignant Middle Cerebral Artery Stroke

Loading next page...
 
/lp/american-medical-association/outcomes-of-hypothermia-in-addition-to-decompressive-hemicraniectomy-lx9n0eajtG

References (30)

Publisher
American Medical Association
Copyright
Copyright 2019 American Medical Association. All Rights Reserved.
ISSN
2168-6149
eISSN
2168-6157
DOI
10.1001/jamaneurol.2018.4822
Publisher site
See Article on Publisher Site

Abstract

Key PointsQuestionDoes moderate hypothermia after decompressive hemicraniectomy reduce early mortality in patients with malignant stroke? FindingsThis randomized clinical trial investigated the effects and safety of moderate hypothermia (temperature, 33°C ± 1°C) after hemicraniectomy in 50 patients 60 years and younger who had malignant stroke. Mortality at day 14 was not significantly different between the hypothermia group and the control group; the trial was terminated early for safety reasons because of a higher rate of serious adverse events in the hypothermia group. MeaningModerate hypothermia after hemicraniectomy did not improve early mortality but may be harmful to patients with malignant stroke.

Journal

JAMA NeurologyAmerican Medical Association

Published: May 18, 2019

There are no references for this article.